CD86 Blocking Peptide

General Information

Product

CD86 Peptide

Description

Antigenic Blocking Peptide T-lymphocyte activation antigen CD86

Verified Applications

Immunodepletion/Immunocompetition Assay

Peptide Description

Synthetic Peptide

Accession #

NCBI:  NP_787058

Physical Properties

Quantity

250 µg

Volume

100 µl

Form

Antigenic Blocking Peptide

Storage

-20⁰C for long term storage

Application Protocol

Competition/Depletion assay

Refer to competition assay protocol

Protein

Uniprot #

P42081

Overview

Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation.

Molecular Function

Receptor; Adaptive Immunity; Host-virus interaction; Immunity

Subcellular Location

Cell membrane; Single-pass type I membrane protein

Expression

Expressed by activated B-lymphocytes and monocytes.

Structure

Contains 1 Ig-like C2-type (immunoglobulin-like) domain.  Contains 1 Ig-like V-type (immunoglobulin-like) domain.

Alternative Nomenclature

Activation B7 2 antigen antibody

B-lymphocyte activation antigen B7-2 antibody

B7 2 antibody

B70 antibody

BU63 antibody

CD 86 antibody

CD28 antigen ligand 2 2 antibody

CLS1 antibody

CTLA 4 counter receptor B7 2 antibody

Early T-cell costimulatory molecule 1 antibody

ETC-1 antibody

FUN 1 antibody

LAB72 antibody

Ly-58 antibody

MB7-2 antibody

Membrane glycoprotein antibody

MGC34413 antibody

T-lymphocyte activation antigen CD86 antibody

TS/A-2 antibody